Abstract:BackgroundCardiac Implantable Electronic Devices (CIEDs) are widely used for the management of advanced heart failure and ventricular arrhythmias. CIED‐Infection (CIED‐I) has very high mortality, especially in the subsets of patients with limited health‐care access and delayed presentation. The purpose of this study is to identify the risk‐predictors mortality in subjects with CIED‐I.MethodsWe performed a retrospective cohort study of a regional database in patients presenting with CIED infections to tertiary care medical centers across Western New York, USA from 2012 – 2020. The clinical outcomes included recurrent device infection (any admission for CIED‐I after the first hospitalization for device infection), septic complications (pulmonary embolism, respiratory failure, septic shock, decompensated HF, acute kidney injury) and mortality outcomes (death during hospitalization, within 30 days from CIED‐I, and within 1 year from CIED‐I). We studied associations between categorical variables and hard outcomes using chi‐square tests and used one‐way analysis of variance to measure between‐groups differences.ResultsWe identified 296 patients with CIED‐I, among which 218 (74%) were male, 237 (80%) were white and the mean age at the time of infection was 69.2±13.7 years. One‐third of the patients were referred from the regional facilities. Staphylococcus aureus was responsible for most infections, followed by Enterococcus fecalis. On multivariate analysis, the covariates associated with significantly increased mortality risk included referral from regional facility (OR: 2.0;1.0‐4.0), hypertension (Odds ratio, OR: 3.2;1.3‐8.8), right ventricular dysfunction (OR: 2.6;1.2‐5.1), end‐stage renal disease (OR: 2.6;1.1‐6.2), immunosuppression (OR: 11.4;2.5‐53.3), and septic shock as a complication of CIED‐I (OR: 3.9;1.3‐10.8).ConclusionHypertension, right ventricular dysfunction, immunosuppression, and end‐stage renal disease are associated with higher mortality after CIED‐I. Disproportionately higher mortality was also noted in subjects referred from the regional facilities. This underscores the importance of early clinical risk‐assessment, and the need for a robust referral infrastructure to improve patient outcomes.This article is protected by copyright. All rights reserved.

Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades A Population-Based Study

Complex cardiac implantable electronic device infections in Alberta, Canada: An epidemiologic cohort study of validated administrative data

Factors associated with cardiac implantable electronic device‐related infections, New South Wales, 2016–21: a retrospective cohort study

Trends and disparities in cardiac implantable electronic device infection‐related mortality in the United States

Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes

Risk Factors Associated with Higher Mortality in Patients with Cardiac Implantable Electronic Device Infection

Cardiovascular Implantable Electronic Device Infections: A Contemporary Review

Abstract 14907: Trends in Management Practices of Cardiovascular Implantable Electronic Device Infections in Patients With End-Stage Kidney Disease

Incidence of infections related to cardiac implantable electronic devices in Germany

Risk of Cardiovascular Implantable Electronic Device Infection in Patients Presenting With Gram-Negative Bacteremia

Abstract 15148: Contemporary Trends of Antibacterial Envelope Use to Prevent Cardiac Implantable Device Infection: Insights From the National Readmission Database

Measures to Prevent Infection in Cardiac Implantable Electronic Device Replacements or Upgrades

Prevalence of cardiac implantable electronic device infections in Germany in 2015

Cardiac surgery in patients with cardiac implantable electronic devices and risk of device infections: a nationwide nested case–control study

Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study

Prevention and Management of Cardiac Implantable Electronic Device Infections: State-of-the-Art and Future Directions

Abstract 9520: Referral From a Regional Facility is Associated With Higher One Year Mortality in Patients With Infected Cardiovascular Implantable Electronic Devices

Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association

Contemporary Management of Cardiac Implantable Electronic Device Infection: The American College of Cardiology COGNITO Survey

Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry

Genetic Identification and Risk Factor Analysis of Asymptomatic Bacterial Colonization on Cardiovascular Implantable Electronic Devices